Shares of ZimVie (NASDAQ:ZIMV) climbed ~13% premarket Thursday after Bloomberg reported that South Korean dental implant maker Osstem is in advanced talks to acquire the U.S.-based MedTech firm.
Bloomberg reported in June and July that Zimvie was an acquisition target for South Korean dental implant maker Osstem Implants. On the surface, the acquisition seemed logical: Zimvie, the #5 ...